Scientific Program
Friday, September 12, 2025
| 08:00-08:15 |
Congress Opening |
Hall A |
|
Welcome message on behalf of the Congress chairpersons
Bruce Mann, Melbourne, Australia
Alastair Thompson, Houston, TX, USA
Henry Gomez Moreno, Lima, Peru
Luis Pinillos, Lima, Peru
Mauricio León Rivera, Lima, Peru |
| 08:15-09:30 |
Session 1: Neoadjuvant therapy |
Hall A |
| Chairpersons |
Bruce Mann, Melbourne, Australia
Carlos Vallejos, Lima, Peru
|
08:15-08:45
08:15
08:25
08:35 |
Debate: That cT1cN0 HER2+ve should have Neoadjuvant Systemic Therapy (NAST)
Yes: Javier Cortes, Madrid, Spain
No: Richard de Boer, Melbourne, Australia
Discussion |
| 08:45-09:00 |
Didactic: Imaging before and during NAST
Karla Sepulveda, Houston, TX, USA |
09:00-09:30
09:00
09:10
09:20 |
Debate: That endocrine therapy is neoadjuvant treatment of choice for ER+ve/HER2-ve disease
Yes: Antonio Llombart, Valencia, Spain
No: Henry Gomez Moreno, Lima, Peru
Discussion |
| 09:30-10:15 |
Mid-morning Symposium: |
Hall A |
| Chairperson |
|
| Speaker |
|
| 10:15-10:45 |
Coffee break, poster viewing and exhibition visit |
| 10:45-11:45 |
Session 2: Surgery |
Hall A |
| Chairpersons |
Luis Pinillos, Lima, Peru
Rafael Vázquez, Mexico City, Mexico
|
10:45-11:15
10:45
10:55
11:05 |
Debate: Breast conservation, not mastectomy, should be the standard of care for T2 cancers
Yes: Shelley Potter, Bristol, UK
No: Nereida Esparza-Arias, Mexico City, Mexico
Discussion |
11:15-11:45
11:15
11:25
11:35 |
Debate: Radiation therapy should be given to all women under 70 having breast conservation for invasive cancer
Yes: David Antonio Martínez Pérez, Medellin-Antioquia, Colombia
No: Mauricio León Rivera, Lima, Peru
Discussion |
| 11:45-12:45 |
Session 3: Screening |
Hall A |
| Chairpersons |
Silvia Falcon, Lima, Peru
Gerardo Castorena, Mexico City, Mexico |
11:45-12:15
11:45
11:55
12:05 |
Debate: That all countries should invest in population-based mammographic screening
Yes: Karla Sepulveda, Houston, TX, USA
No: Monique Gary, Sellersville, PA, USA
Discussion |
| 12:15-12:45 |
Didactic: Artificial Intelligence to advance breast cancer screening
Karla Sepulveda, Houston, TX, USA |
| 12:45-13:45 |
Lunch break, poster viewing and exhibition visit |
| 13:45-14:15 |
Session 4: Case discussions |
Hall A |
| Moderator |
Lia Pamela Rebaza, Lima, Peru |
| Panel of experts |
Imager: Rosa Cebrian, Lima, Peru
Medical oncologist: Zaida Morante, Lima, Peru
Surgeon: Yanet Carrasco Rojas, Arequipa, Peru
Radiation oncologist: Joseana Ayala, Lima, Peru
Pathologist: Andrea Gomero, Lima, Peru
|
| 14:15-15:45 |
Session 5: HER2+ve disease |
Hall A |
| Chairpersons |
Adriana Freitas, Santa Catarina, Brazil
Javier Cortes, Madrid, Spain |
14:15-14:45
14:15
14:25
14:35 |
Debate: Do anthracyclines still have a place in the treatment of early stage HER2+ve BC?
Yes: Antonio Llombart, Valencia, Spain
No: Richard de Boer, Melbourne, Australia
Discussion |
14:45-15:15
14:45
14:55
15:05 |
Didactic: Understanding HER2 low disease – how to diagnose/how to treat?
Diagnose: Nirmala Pathmanathan, Sydney, Australia
Treat: Jesus Schwartz, Lima, Peru
Discussion |
15:15-15:45
15:15
15:25
15:35 |
Debate: Axillary radiation is better than surgery after neoadjuvant treatment for node positive disease
Yes: Gustavo Luyo, Lima, Peru
No: Stuart McIntosh, Belfast, UK
Discussion |
| 15:45-16:30 |
Mid-afternoon Symposium: |
Hall A |
| Chairperson |
|
| Speaker |
|
| 16:30-16:50 |
Coffee break, poster viewing and exhibition visit |
| 16:50-17:50 |
Session 6: HR+ve Metastatic Breast Cancer (MBC) |
Hall A |
| Chairpersons |
Daniel Lee Kay Pen, Lima, Peru
Natalia Valdivieso, Lima, Peru |
16:50-17:20
16:50
17:00
17:10 |
Debate: Endocrine therapy should be given as 1st line therapy for ALL patients with ER+ve MBC
Yes: Gerson Mejia, Cochabamba, Bolivia
No: Walter Li, Lima, Peru
Discussion |
17:20-17:50
17:20
17:27
17:34
17:41 |
Didactic: What to do after first progression of ER+ breast cancer on three continents: Change ET, CDK4/6i or SERDS?
Javier Cortes, Madrid, Spain
Richard de Boer, Melbourne, Australia
Natalia Valdivieso,Lima, Peru
Discussion |
| 17:50-18:20 |
Poster Session |
| 19:00-21:00 |
Welcome Reception |
Saturday, September 13, 2025
| 08:30-09:30 |
Session 7: ER+ breast cancer
|
Hall A |
| Chairpersons |
Enrique Bargallo, Mexico City, Mexico
Alastair Thompson, Houston, TX, USA |
08:30-09:00
08:30
08:40
08:50
|
Debate: All patients should use AI? And for how long?
Yes: Gerson Mejia, Cochabamba, Bolivia
No: Silvia Falcon, Lima, Peru
Discussion |
09:00-09:30
09:00
09:10
09:20 |
Debate: Postmenopausal women with clinical T1N0 ER+ breast cancer do not need axillary surgery
Yes: Lia Pamela Rebaza, Lima, Peru
No: Bruce Mann, Melbourne, Australia
Discussion |
| 09:30-10:15 |
Mid-morning Symposium: |
Hall A |
| Chairperson |
|
| Speaker |
|
| 10:15-10:45 |
Coffee break, poster viewing and exhibition visit |
| 10:45-11:45 |
Session 8: Triple negative breast cancer |
Hall A |
| Chairpersons |
Richard De Boer, Melbourne, Australia
Shelley Potter, Bristol, UK
|
10:45-11:15
10:45
10:55
11:05 |
Debate: That all stage 2 TNBC patients should be treated according to the Keynote 522 regimen
Yes: Javier Cortes, Madrid, Spain
No: Henry Gomez Moreno, Lima, Peru
Discussion |
| 11:15-11:45 |
Didactic: TNBC subtypes: How do we use them to help patient outcomes?
Nirmala Pathmanathan, Sydney, Australia |
| 11:45-12:15 |
Session 9: Case Discussions |
Hall A |
| Moderator |
Ronald Limon, Santa Cruz de la Sierra, Bolivia |
| Panel of experts |
Imager: Liana Falcon, Lima, Peru
Medical oncologist: Natalia Valdivieso, Lima, Peru
Surgeon: Andy Pantoja, Trujillo, Peru
Radiation oncologist: Alberto Lachos, Lima, Peru
Pathologist: Franco Doimi, Lima, Peru |
| 12:15-13:15 |
Session 10: Reducing the risk |
Hall A |
| Chairpersons |
Karla Sepulveda, Houston, TX, USA
Mauricio León Rivera, Lima, Peru |
12:15-12:45
12:15
12:25
12:35 |
Debate: All women under 50 with gene mutations should be offered bilateral mastectomy
Yes: Lia Pamela Rebaza, Lima, Peru
No: Stuart McIntosh, Belfast, UK
Discussion |
12:45-13:15
12:45
12:55
13:05 |
Debate: All women presenting with nodal disease should have radiation therapy after mastectomy
Yes: Oscar Niño De Guzman, Cochabamba, Bolivia
No: Valentina Ovalle, Santiago, Chile
Discussion |
| 13:15-14:15 |
Lunch break, poster viewing and exhibition visit |
| 14:15-15:45 |
Session 11: Adjuvant endocrine therapy |
Hall A |
| Chairpersons |
Nirmala Pathmanathan, Sydney, Australia
Rafael Vázquez, Mexico City, Mexico
|
| 14:15-14:55 |
Pitching the test in five minutes: Why this test is “best”? |
| 14:15
14:25
14:35
14:45 |
PAM50: Javier Cortes, Madrid, Spain
Oncotytpe/ODX: Henry Gomez Moreno, Lima, Peru
Mammaprint: Alastair Thompson, Houston, TX, USA
Pathology: Henry Guerra, Lima, Peru |
| 14:55-15:15 |
Didactic: Risk assessment (summary) for ER+ breast cancer
Antonio Llombart, Valencia, Spain |
15:15-15:45
15:15
15:25
15:35 |
Debate: That all young women treated with OFS should be given an aromatase inhibitor
Yes: Alastair Thompson, Houston, TX, USA
No: Richard De Boer, Melbourne, Australia
Discussion |
| 15:45-16:30 |
Mid-afternoon Symposium: |
Hall A |
| Chairperson |
|
| Speaker |
|
| 16:30-16:50 |
Coffee break, poster viewing and exhibition visit |
| 16:50-17:50 |
Session 12: Locoregional management |
Hall A |
| Chairpersons |
Lia Pamela Rebaza, Lima, Peru |
16:50-17:20
16:00
17:00
17:10 |
Debate: That patients with heavy axillary nodal disease pre-NACT should have axillary dissection irrespective of response to NACT
Yes: Enrique Bargallo, Mexico City, Mexico
No: Bruce Mann, Melbourne, Australia
Discussion |
| 17:20-17:50 |
Case discussions: Focusing on Locoregional management |
|
| Moderator |
Mauricio León Rivera, Lima, Peru |
|
| Panel of experts |
Medical oncologist: Luis Orrego, Lima, Peru
Imager: Pilar Montenegro, Lima, Peru
Surgeon: Oscar Niño De Guzman, Cochabamba, Bolivia
Radiation oncologist: Juan Manuel Trejo, Lima, Peru
Pathologist: Henry Guerra, Lima, Peru
|
|
| 17:50-18:00 |
Congress closing and Award presentation |
Hall A |
|
Bruce Mann, Melbourne, Australia
Alastair Thompson, Houston, TX, USA
Henry Gomez Moreno, Lima, Peru
Luis Pinillos, Lima, Peru
Mauricio León Rivera, Lima, Peru |
- Program is subject to change
